Last reviewed · How we verify
Lidocaine 5% patch — Competitive Intelligence Brief
marketed
Local anesthetic
Voltage-gated sodium channels
Pain management / Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Lidocaine 5% patch (Lidocaine 5% patch) — Beijing Tiantan Hospital. Lidocaine blocks sodium channels in nerve fibers, preventing the initiation and conduction of nerve impulses to produce local anesthesia.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lidocaine 5% patch TARGET | Lidocaine 5% patch | Beijing Tiantan Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Propofol/Lidocaine | Propofol/Lidocaine | NYU Langone Health | marketed | Intravenous anesthetic combination | GABA-A receptor (propofol); voltage-gated sodium channels (lidocaine) | |
| Dexamethasone+ Bupivacaine | Dexamethasone+ Bupivacaine | Ain Shams University | marketed | Corticosteroid + Local anesthetic combination | Glucocorticoid receptor (dexamethasone); Voltage-gated sodium channels (bupivacaine) | |
| Bupivacaine (Marcaine) | Bupivacaine (Marcaine) | NYU Langone Health | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| Control (bupivacaine) | Control (bupivacaine) | Kasr El Aini Hospital | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| Suzetrigine (SUZ) | Suzetrigine (SUZ) | Vertex Pharmaceuticals Incorporated | marketed | Selective sodium channel inhibitor | Voltage-gated sodium channels (Nav) | |
| lamotrigine (generic Teva) | lamotrigine (generic Teva) | University of Maryland, Baltimore | marketed | Anticonvulsant / Mood stabilizer | Voltage-gated sodium channels; glutamate release inhibition |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic class)
- University of California, San Diego · 3 drugs in this class
- Durect · 3 drugs in this class
- Pacira Pharmaceuticals, Inc · 3 drugs in this class
- Wake Forest University Health Sciences · 3 drugs in this class
- Medical University of Vienna · 3 drugs in this class
- Imperial College London · 2 drugs in this class
- Hvidovre University Hospital · 2 drugs in this class
- Innocoll · 2 drugs in this class
- George Washington University · 2 drugs in this class
- Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lidocaine 5% patch CI watch — RSS
- Lidocaine 5% patch CI watch — Atom
- Lidocaine 5% patch CI watch — JSON
- Lidocaine 5% patch alone — RSS
- Whole Local anesthetic class — RSS
Cite this brief
Drug Landscape (2026). Lidocaine 5% patch — Competitive Intelligence Brief. https://druglandscape.com/ci/lidocaine-5-patch. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab